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Abstract
Malaria remains as one of the most devastating infectious disease, and continues to exact an enormous toll in medical cost
and days of labor lost especially in the tropics. Effective malaria control and eventual eradication remain a huge challenge,
with efficacious antimalarials as important intervention/management tool. Clearly new alternative drugs that are more
affordable and with fewer side effects are desirable. After preliminary in vitro assays with plant growth regulators and
inhibitors, here, we focus on biosynthetic inhibitors of gibberellin, a plant hormone with many important roles in plant
growth, and show their inhibitory effect on the growth of both apicomplexa, Plasmodium falciparum and Toxoplasma
gondii. Treatment of P. falciparum cultures with the gibberellin biosynthetic inhibitors resulted in marked morphological
changes that can be reversed to a certain degree under hyperosmotic environment. These unique observations suggest
that changes in the parasite membrane permeability may explain the pleiotropic effects observed within the intracellular
parasites.
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Introduction
Malaria, caused by the genus Plasmodium, is one of the most
common infections in the world responsible for about 1 million
deaths per year. Artemisinin-based combination therapies (ACTs)
are currently the first-line and only the best weapon against
malaria [1]. Drug resistance, which rendered chloroquine and
sulfadoxine-pyrimethamine infective for malaria control from
1970 to 1990s, remains as one of the greatest challenges facing
malaria control today. Besides, ACT is 4 to 226more expensive
than common drugs and access is generally poor in African
countries [2]. Also, although its clinical efficacy has not yet been
compromised, there are recent reports that show the first evidence
of artemisinin resistance [3]. Admittedly, the development of new
inexpensive, effective and safe drugs with new mechanisms is
strongly needed.
Plant-specific organelles and mechanisms in the phylum
Apicomplexa, in which Plasmodium and other medically and
veterinarily important pathogens are included, have been brought
to focus as potential targets for new drugs since associated enzymes
were found in plants and bacteria but not in animal metabolic
pathways. Examples of these are plant-like vacuoles in parasite
cells and the mevalonate-independent biosynthesis of isoprenoid in
apicoplasts [4], [5]. The rationale was further strengthened with
the demonstration that the apicoplast is essential for malaria
parasite survival [6] and that metabolic pathways in the apicoplast
are essential for parasite growth [7]. In addition, identification of
inhibitors in these pathways might also result in synergistic drug
combinations, which could have increased therapeutic value. The
plant hormone abscisic acid (ABA) and ABA biosynthetic
inhibitors have, likewise, been shown to affect parasite egress
from infected host cells in Toxoplasma gondii [8].
In this study, we have preliminarily explored a wide variety of
plant growth regulators, including plant hormones and corre-
sponding inhibitors, to investigate their effect(s) on the growth of
the most virulent human malaria parasite, Plasmodium falciparum.
We have also used the apicomplexan parasite, T. gondii for
comparison. T. gondii infects a broad spectrum of hosts and
efficient drugs with low side effects and usable for human therapies
are also highly needed. Plant growth inhibitors are commonly used
in agriculture for years and have been synthesized in bulk,
efficiently and cheaply, either naturally or artificially. Well-
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safety profile (toxicity and teratogenicity) in animals, crops and
humans are also available. Thus, plant growth inhibitors showing
anti-apicomplexan activities might give valuable clues for
prophylactic or therapeutic reagents effective for infectious
diseases caused by protozoan parasites.
Materials and Methods
Chemicals
AMO-1618 (2-isopropyl-4-dimethylamino-5-methyl-phenyl-1-
piperidinecarboxylate methyl chloride) was obtained from CAL-
BIOCHEM (La Jolla, USA). FC-907 [N,N,N,-trimethyl-1-methyl-
(29,69,69-trimethylcyclohex-29-en-19-yl)prop-2-enylammonium io-
dide] was kindly provided by Prof. Y. Kamiya (RIKEN, Japan).
LysoTrackerH Red DND-99 was obtained from Invitrogen (San
Diego, USA). All other chemicals were purchased from Wako
Pure Chemicals (Osaka, Japan).
Prior to use and dilution at various concentrations, AMO-1618,
chlorocholine chloride, prohexadione and FC-907 were dissolved
in distilled water. INA and ancymidol were dissolved in DMSO
and diluted in 0.1% DMSO. Paclobutrazol and uniconazole P
were dissolved in ethanol and diluted in the culture medium.
Enantiomeric resolution of racemic INA (Wako) was carried out
by high performance liquid chromatography (HPLC; LC-908,
Japan Analytical Industry Co., Ltd, Japan). Elution order of
enantiomers was determined by an ultraviolet absorption detector
(SPD-10A, Shimadzu, Japan) using Chiralcel OD column
[2560.46 cm, Daicel Chemical Industries, Japan, mobile phase:
n-hexane-2-propanol (7:3, v/v), flow rate: 1.0 ml/min]. All
resolutions were carried out at 26uC; detection at 275 nm. The
assignment of the peaks was achieved by comparison with the
synthesized (S)-form INA sample as previously described [9]: peak
with shorter retention time correspond to the (R)-form and the
peak with longer retention time to the (S)-form. Percentage purity
of the products was calculated to be 97.0% and 99.5% for (S)- and
(R)-forms, respectively, based on peak areas.
In vitro culture
P. falciparum strain 3D7 was cultured at 3% hematocrit in RPMI
1640 supplemented with 10% human serum, 50 mg/l hypoxan-
thine and 25 mg/l gentamicin, as previously described [10].
Cultures were maintained at 37uC in a gas mixture of 5% CO2,
5% O2, and 90% N2.
The T. gondii strain 2F tachyzoites, derived from strain RH,
constitutively expressing cytoplasmic b-galactosidase (b-gal), were
routinely grown in Vero cells (African green monkey kidney, strain
ATCC CCL-81
TM)a t3 7 uC under 5% CO2 in RPMI 1640
medium containing 10% fetal calf serum [11].
In vitro antimalarial assay of plant growth regulators
Asynchronous P. falciparum 3D7 was used. Various concentra-
tions of compounds in appropriate solvents (water, ethanol or
DMSO) were prepared and added to 12-well plates. Starting
parasitemia was at 0.1% in 2.5 ml culture medium. Growth was
assessed after 72 h by percentage parasitemia using thin blood
smears. The number of parasitized erythrocytes over a total of
3,000 erythrocytes was examined. Drug-free control cultures were
run simultaneously.
For T. gondii studies, confluent Vero cell cultures were incubated
for 2 days and infected with 2.5610
5 tachyzoites in RPMI 1640
medium containing 3% FCS using a 96-well plate. Tachyzoites
were harvested after 2 days and b-gal activity was analyzed using a
colorimetric assay [12].
Morphological effects of gibberellin biosynthetic
inhibitors on P. falciparum
Tightly synchronized parasites within 4 h life span were
prepared using 5% sorbitol treatment and percoll centrifugation.
Synchronized parasites were treated with either 50 mM INA or
250 mM AMO-1618 from 0 h (ring), 20 h (immature trophozoite),
28 h (mature trophozoite) or 36 h (schizont). Giemsa-stained thin-
blood smears were prepared after 4, 8 and 12 h treatment. Digital
imaging was performed on a HC-300 (Fujifilm, Japan) and
representative parasite images are shown.
Fluorescence Microscopy
Thin-blood smears of infected erythrocytes treated with INA
were stained with acridine orange (100 mg/ml). Fluorescence
microscopy and confocal imaging were carried out using the
Axioplan 2 microscope (Zeiss, German) and SPOT PS-BW CCD
camera (Seki Technotron Corp., Japan). Filter sets for green
fluorescence (green: nucleoli; emission LP515, excitation BP 450–
490) and red fluorescence (red: cytoplasm; emission LP590,
excitation 546/12) were used. Nile Red staining was carried out
by addition of 1 mg/ml dye to the culture medium 1 h prior to
microscopic analysis. Nile Red was excited at 546 nm and
emission detected above 590 nm. To stain with rhodamine 123
and LysoTrackerH Red DND-99, 10 ng/ml rhodamine or 75 nM
LysoTracker were added to the culture and incubated for 1 h.
Confocal images were obtained with excitation above 546 nm and
emission above 590 nm.
Electron microscopy
Intraerythrocytic parasites treated with 50 mM INA for 6 h,
250 mM AMO-1618 for 8 h or 0.1% DMSO for 6 h were
centrifuged at 35006g for 1 min and fixed in 2% glutaraldehyde
in 16 PBS for 1 h. After washing in 16 PBS, fixed cells were
treated as described [13]. Sections were viewed in a transmission
electron microscope JEM-1011 (JEOL Ltd., Japan).
Effects of osmotic pressure on INA-treated P. falciparum
P. falciparum in RPMI 1640 containing 10% human serum was
grown to 5–10% parasitemia and synchronized by sorbitol
treatment. After 21 h, 0.9 ml of early trophozoite-stage parasites
was mixed with 0.1 ml of 16,2 6,3 6 and 46 PBS and treated
simultaneously with 50 mM INA or 0.1% DMSO for 8 h (INA
stock solution was prepared as 50 mM in DMSO and diluted to 1/
1000 for assay). Parasitemia was determined using Giemsa-stained
thin smears by a laboratory technician blinded to treatment
assignments. Each treatment was replicated thrice and experi-
ments were performed twice.
Volumes of 0, 0.1, 0.2 and 0.4 ml sterilized water was adjusted
to 0.4 ml by mixing with appropriate amounts of RPMI 1640
medium containing 10% human serum for the different dilution
series. Hyposmotic media were mixed with 0.6 ml of P. falciparum
culture synchronized to early-stage trophozoites.
GC-MS analysis of sterols in P. falciparum
Parasites were cultured in 5 ml RPMI 1640 supplemented with
1% serum free AlbuMAXH II (Invitrogen). Parasitized erythro-
cytes were collected by centrifugation and hemolyzed in 0.54 ml of
0.15% saponin in RPMI 1640. Erythrocyte-free parasites were
washed twice with 4 ml of 16PBS and suspended in 0.4 ml of 16
PBS. Geranylgeraniol at 50 mg was added to the suspension as an
internal standard and extraction with 1 ml of chloroform was
carried out 3 times by shaking the mixture at 37uC.
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injected into the GC-MS (gas chromatography/mass spectroscopy)
instrument (JEOL; JMS-Bu25 GCMate: ionization energy at
70 eV, filament current at 300 mA) with a DB-5 capillary column
[0.25 mm i.d.615 m, film thickness of 0.25 mm (J&W Scientific,
USA)]. The He carrier gas flow rate was 1 ml/min (constant flow),
the injector temperature was 250uC, and the samples were
introduced by splitless injection. After injection, the oven temper-
ature program was held at 80uC for 1 min, then increased to 200uC
at 30uC min
21, followed by a further increase to 300uCa t1 5 uC
min
21 after which it was held constant at 300uC for 2 min.
For quantitative analysis, commercially available cholesterol
and geranylgeraniol (Sigma) was detected by GC-MS and
corresponding peaks were used as authentic standards for
cholesterol and geranylgeraniol, respectively. Cholesterol was
calculated based on ratio of peak areas with geranylgeraniol.
Results
Antimalarial activity of gibberellin biosynthetic inhibitors
All inhibitors of gibberellin used in this study affect synthesis of
gibberellin in plants (Fig. 1). Generally, the inhibitors blocked P.
falciparum growth in vitro (Table 1, Fig. S1); although, results were
admittedly different among the inhibitors as well as between
Plasmodium and Toxoplasma. For example, inabenfide (INA) exerted
strong activities in both P. falciparum and T. gondii, whereas
prohexadione exhibited no cytotoxicity to P. falciparum even at
500 mM. Likewise, ED50s of some inhibitors varied greatly between
P. falciparum and T. gondii, such as AMO-1618: 10.362.22 mMi nP.
falciparum and .1000 mMi nT. gondii. Apparent difference in
effective inhibitor concentrations between the two parasite species
could be species-specific barrier on membranes for drug uptake or
inhibitory mechanisms in P. falciparum and T. gondii [14].
Some of the tested inhibitors have an asymmetric carbon, and
their enantiomers are known to differ significantly in their
biological properties [15]. (S)-forms are biologically more active
than (R)-forms in higher plants [16]. In order to examine the
chirality effect of these inhibitors, we separated enantiomers from
commercially available INA by HPLC using a chiral column (Fig.
S2) since marketed INA is racemic. The (S)-form was slightly more
potent than the (R)-form, as demonstrated by ED50 values of
2.7860.51 mM and 6.3260.81 mM, respectively in P. falciparum
(Table 1). Notably, the (R)-form was more effective in inhibiting
growth of T. gondii.
Figure 1. Isoprenoid biosynthetic pathways and known inhibitors in various organisms. Broken arrows indicate blocks in the biosynthesis
due to specific inhibitors. ‘‘R’’ indicates various functional groups specific to individual compounds. CPPS, copalyl-diphosphate synthase (EC 5.5.1.13);
KO, ent-kaurene oxidase (EC 1.14.13.78); CAS, cycloartenol synthase (EC 5.4.99.8); LS, lanosterol synthase (EC 5.4.99.7); KS, ent-kaurene synthase (EC
4.2.3.19); PP, pyrophosphate.
doi:10.1371/journal.pone.0032246.g001
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biosynthetic inhibitors
We also evaluated morphological and physiological effects
induced by the gibberellin biosynthetic inhibitors. In what appears
to be the center of the parasite, a Giemsa-unstained region was
prominent within 4 h after treatment with INA (Fig. 2 B). The
‘‘haloed’’ parasites swelled and ruptured within 12 h of culture in
immature trophozoite-stage. Rings were seldom found when early
trophozoite-stage parasites were treated with INA. When INA was
applied at late stages of the parasite, i.e. in mature trophozoites and
schizonts, a similar swelling was also observed although the stained
periphery appears broader with merozoites bloated in appearance
and few in number (Fig. 2 C, D). Ring-stage treated parasite
cultures were usually applique ´ forms (rings appearing on the
periphery of the erythrocytes) (Fig. 2 A).
Another type of gibberellin biosynthetic inhibitors, AMO-1618
and FC-907, which prevent cyclization reaction in the early steps
of gibberellin biosynthesis (Fig. 1) [15], [17], also caused parasite
cells to swell. Swelled parasites were found within 8 h and 24 h
after AMO-1618 treatment (Fig. 2, S3), but the altered
morphology on schizonts was different: parasites appear abnor-
mally disordered inside erythrocytes (Fig. 2 C, D). A similar
morphological change in Plasmodium cultures were observed when
greater than 2 mM INA were used (data not shown). Notably, both
INA and AMO-1618 did not appear to damage erythrocytes,
because P. falciparum could infect erythrocytes that had been
treated for 24 h with 50 mM INA or 250 mM AMO-1618 without
any significant inhibitory effects (Fig. S4).
At 2 mM, INA-induced morphological changes were micro-
scopically visible at 24 h in asynchronous parasite cultures. In
order to determine if INA and AMO-1618 targets a specific stage
during intraerythrocytic development, we increased concentra-
tions of INA to 50 mM and AMO-1618 to 250 mM. Both
inhibitors at these concentrations provoked morphological changes
more rapidly than concentrations at their ED50s (Fig. S5). The use
of increased concentrations of inhibitors also allowed us to
measure the intrinsic sensitivity of the parasites in vitro, and
provided clues to the maximal response that can be produced by
these inhibitors, as well as their toxicity to the human erythrocytes.
Even after 24 h incubation, use of 0.1% DMSO alone gave no
effects on growth and morphology of malaria parasites. Parasite
swelling and rupture was also observed on P. falciparum cultures
treated with other gibberellin biosynthetic inhibitors, such as
paclobutrazol and uniconazole P (Fig. S5). These inhibitors, as
well as INA, are known to block cytochrome P450-dependent
monooxygenases (CYP701A) in plants [15]. Interestingly, the time
and the concentrations necessary to provoke morphological
changes were different among these compounds, presumably
due to differences in solubility and lipophilicity.
The ‘haloed’ trophozoites
The ‘‘haloed’’ parasites were stained with various fluorescent
probes to visualize intracellular components. The center of the
trophozoites was not stained with acridine orange (Fig. 3 A). Both
nuclei and cytoplasm appear to be on the periphery, as seen in the
Giemsa-stained images. Nile Red, used to visualize various lipid-
rich compartments such as membranes, endoplasmic reticulum
(ER) and lipid bodies [18], revealed a simpler staining pattern
surrounding what appears to be fewer merozoites in contrast to the
control. Merozoites also appear bloated with intense spots of
fluorescence (presumed as lipid bodies, Fig. 3 B). In normal mature
stage trophozoites, rhodamine 123 showed thread-like branched
mitochondria, characteristic of the mitochondrial development at
the later stages where each daughter merozoite receives a branch
of the parent organelle (Fig. 3 C) [19]. In INA-treated parasites,
however, branched mitochondria were rarely seen. Although
fluorescence intensity in the mitochondria started to decrease after
2 h, parasites still have significant fluorescence over the entire
parasite cytosol, except in the food vacuole, similar to untreated
parasite cells. This observation suggest a membrane potential
generated by the parasite’s outer plasma membrane [20], [21] and
that INA effect likely induced a specific reduction in the
mitochondrial membrane potential alone.
These differences in the staining patterns were not evident when
ring-stage parasites were observed (data not shown), which suggest
that various membranes were remarkably affected by INA only
when parasites reached the trophozoite stage. The timing is
coincident at a time when the parasite starts to actively generate
membranes needed for growth and schizogony [22].
Electron microscopy also revealed fine intracellular differences at
the trophozoite and schizont-stage parasite (Fig. 4 A, B). When
trophozoites were treated with INA or AMO-1618 (Fig. 4 A),
membranes of the nuclear envelope and ER were thicker and
intensely stained compared to control parasites. Conspicuously
unfamiliar spaces appeared around the ER and daughter nuclei
(Fig. 4 A, INA and AMO-1618 panel). Using asynchronous
cultures, these spaces were more readily observed at mature-stage
parasites than early trophozoites (Fig. 4 B, b and f vs. c and d). No
differences were evident in the plasma membranes of both host and
parasite cells during the intraerythrocytic life cycle (Fig. 4 B). These
results suggest that the gibberellin biosynthetic inhibitors appear to
affect components of various intracellular membranes of the
parasites, and the effects were especially evident during schizogony.
INA effect and osmotic pressure in parasite cells
Various stressful conditions were applied to INA treated
parasite: use of hydraulic pressure, ultrasound, pH (5–9) and
temperature changes (4–37uC); but no differences were observed
when compared to control parasites (DMSO-treated). However,
different responses were seen when trophozoite-stage parasites
were under various osmotic stress. Hyperosmotic conditions were
achieved by incubating with 10% (v/v) 16,2 6,3 6or 46PBS.
For control, untreated parasite cultures, relative parasitemia
drastically decreased with increasing hyperosmotic environment
(Fig. 5 A). However, relative parasitemia in the INA-treated
Table 1. ED50 of the gibberellin biosynthetic inhibitors.
Reagents ED50 of P. falciparum (mM) ED50 of T. gondii (mM)
Chlorocholine Chloride 8.94626.08 .10000
AMO-1618 10.362.22 .1000
FC-907 4.2660.14 2206.762.46
Inabenfide 2.9460.15 17.061.32
Paclobutrazol 27.162.69 120.665.38
Uniconazole P 30.766.20 97.468.66
Ancymidol 322.9613.1 .1000
Prohexadione .500 .10000
(S)-Inabenfide 2.7860.51 24.0461.07
(R)-Inabenfide 6.3260.81 6.2361.65
Growth inhibitory effects of gibberellin biosynthetic inhibitors and enantiomers
of INA to P. falciparum and T. gondii are shown. Values are the mean 6 standard
deviations (SD) from three independent experiments, with each treatment
duplicated twice. N.D.; not determined.
doi:10.1371/journal.pone.0032246.t001
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in cultures treated with 10% 46 PBS. Moreover, ‘haloed’
trophozoites were less evident in cultures incubated with 36 or
46 PBS. To examine the potential effects of cation species, we
made a solution where the net solute was the same to PBS but the
concentrations of Na
+ and K
+ were reversed (137 mM KCl,
8.1 mM K2HPO4, 2.68 mM NaCl, and 1.47 mM NaH2PO4).
Between normal and reversed PBS in the different treatments, no
significant differences were observed in both parasitemia and
morphology (Fig. S6). Exogenously added Ca
2+ (100 mM) to
cultures did not help reverse the ‘haloed’ effects of INA in
trophozoites (Fig. S7).
Hyposmotic stress enhanced INA’s effect in treated parasites:
early trophozoite-stage parasites swelled even more by the addition
of 10% (v/v) water to the culture medium (Fig. 5 B). At 40% (v/v)
water, trophozoites swelled to almost the same volume of the
infected erythrocyte. Decrease in parasitemia was also statistically
significant compared to the control. These observations suggest
that INA treatment might affect membrane permeability; water or
ion influx might cause swelling of the parasites.
Isoprenoid biosynthetic pathway in apicomplexan
parasites
Parasite cultures were incubated with gibberellin A3 and A4, the
most effective gibberellins, with or without gibberellin biosynthetic
inhibitors. Of note, gibberellins did not affect growth of parasites
nor overcome the effects of the inhibitors (data not shown),
suggesting that the inhibitors could not disrupt gibberellin
biosynthesis in P. falciparum or malaria parasites do not utilize
gibberellins.
Gibberellins are diterpene (isoprenoid), ubiquitous and essential
compounds by themselves or as materials of secondary metabolites
Figure 2. Effect of INA and AMO-1618 on intraerythrocytic development of P. falciparum. Tightly synchronized parasite cells that have
undergone 5% sorbitol treatment and percoll density gradient centrifugation (window period: 4 h) were treated with 1 ml/ml DMSO, 50 mM INA or
250 mM AMO-1618 at different parasite stages: after 0 h (ring, A), 20 h (immature trophozoite, B), 28 h (mature trophozoite, C) and 36 h (schizont, D).
Cultures were examined after 4, 8 and 12 h using Giemsa thin blood smears. Scale bar: 3 mm; all images without a scale bar are displayed at the same
scale as the left uppermost image in (A).
doi:10.1371/journal.pone.0032246.g002
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Biosynthetic pathways of isoprenoids are very complicated and
parallel pathways for the biosynthesis of the universal 5-carbon
building block for all terpenoid compounds exist. A huge variety of
sterols and terpenoids are synthesized via isoprenoid metabolic
pathways in a species-specific manner, although all pathways
utilize farnesyl pyrophosphate as a starting molecule generated in
the mevalonate pathway and the 2-C-methyl-D-erythritol 4-
phosphate (MEP) pathway (Fig. 1) [23]. Gibberellin biosynthetic
inhibitors have been known to block other enzymes leading to the
production of sterols and terpenoids. We then analyzed P.
falciparum treated with INA and AMO-1618 by GC-MS.
Interestingly, any sterols or terpenoids besides cholesterol derived
from human erythrocytes were not detected, and there were no
significant differences in the level of cholesterol between control
and INA- or AMO-1618-treated samples (Fig. 6).
Discussion
Efforts on malaria control have been complicated by emergence
of drug resistance. With the apicoplast considered to originate from
an ancestor with an endosymbiotic alga, and that many non-
photosynthetic processes are shared peculiarly with plants, plant
growth regulators are of particular interest for pharmaceutical leads
on the assumption that the molecular target may not be present in
humans. The present study clearly showed some inhibitors that
antagonize gibberellin biosynthesis in plants are effective to both P.
falciparum and T. gondii (Table 1). Gibberellin is one of 5 major plant
hormones known to exert various effects on physiological events,
particularly germination and seed bearing by promoting cell
elongation [24]. 126 different gibberellins are known to occur in
plants [15], and they are synthesized via the mevalonate pathway
and the MEP pathway. Interestingly, gibberellinhasbeenutilized to
induce development of parthenocarpous fruits in some fruits such as
grapes. On the other hand, gibberellin inhibitors have also been
widely used for agriculture, e.g. for dwarf plants without harmful
effects to either plants or animals.
All gibberellin inhibitors tested in this study block biosynthesis of
gibberellin in plants: AMO-1618 and FC-907 block synthesis of ent-
kaurene (an intermediate during the synthesis of gibberellin) by
inhibition of copalyl-diphosphate synthase (CPPS) and ent-kaurene
synthase (KS, Fig. 1) [15]. Next to AMO-1618 and FC-907 steps,
INA, paclobutrazol, uniconazole P and ancymidol interrupt ent-
kaurene oxidase (KO), a member of the cytochrome P450
monooxygenases (CYP) oxidating ent-kaurene into ent-kaurenoic acid.
Azole antifungal such as fluconazole and diniconazole are analogous
compounds to these inhibitors and interrupt synthesis of ergosterol
[25]. They have an asymmetric carbon and their enantiomers are
known to differ significantly in their biological properties [16], [26].
(R)-forms demonstrate stronger activity than (S)-forms in terms of
fungicidal effects, whereas the latter is functionally active and the (R)-
forms showed only residual activity with regard to blockage in plant
gibberellin biosynthesis. We tested the stereochemical selectivity of
INA and found that the (S)-form inhibited growth of P. falciparum .2
times stronger than (R)-form but vice versa in T. gondii (Table 1). The
stereochemical discrimination was, thus, similar to plants than to
fungi in P. falciparum, although the (S)-form was reportedly 1000 times
more potent than (R)-form in growth retardation of pumpkin
seedlings [26]. Differences may be due to discrepancies in protein
structures that relate to membrane permeability or translocation of
the enantiomers to the site of biosynthesis in such distant species.
The observed decrease in parasitemia in INA-treated cultures
correlated with remarkable morphological changes: swelling and
rupture of P. falciparum cells, particularly when drug treatment
commenced during early trophozoite stage (Fig. 2). Trophozoite-
stage parasite cells appear to be ‘haloed’, the center of the cell
remains unstained by Giemsa and acridine orange. Both nuclei
and cytoplasm were seen on the periphery of the parasite cells.
These data suggest that some substances that are neither acidic nor
alkaline might accumulate in the unstained parts.
We also observed the intracellular structures in INA-treated
cultures using different dyes and found that various intracellular
organelles, especially organelles synthesized during schizogony
(such as mitochondria, membrane network and food vacuoles) are
morphologically abnormal or compromised after short treatment
with INA (Fig. 3). Membrane potential in the mitochondria was
reduced rapidly within 2 h of INA treatment. Organelle
membranes such as those in the ER and nuclear envelope
appeared thicker and gaps were observed around such organelles
under electron microscopy (Fig. 4). From these observations, it
appears that gibberellin biosynthetic inhibitors damage the
parasite internal organelles, compromises parasite membranes
and results to abnormalities in the treated parasites.
In order to further probe for clues that can shed light into the
mechanisms for such changes in the membranes, we exposed INA-
treated parasite cells to various stresses, and found that osmotic
pressure modified the effects of INA. Treated parasite cells under
hyperosmotic conditions became less swelled and viability was
significantly restored (Fig. 5 A). In contrast, the addition of water
in the culture medium enhanced expansion and rupture of
parasites (Fig. 5 B). These results demonstrate that INA treatment
might affect permeability of membranes, and consequently result
to uncontrollable influx of water or ion into parasite cells. No
abnormalities in the plasma membrane structure were observed by
electron microscopy (Fig. 4), although this cannot be completely
ruled out since parasites with severely compromised plasma
Figure 3. Fluorescence microscopy of INA-treated parasites.
Infected erythrocytes were stained with (A) acridine orange, (B) Nile Red,
(C) rhodamine 123 and (D) LysoTracker
TM Red DND-99. INA was
introduced at: (A) 100 mM for 9 h, (B) 50 mM for 6 h, and (C and D)
50 mM for 4 h. 100 mg/ml acridine orange was applied to thin blood
smears made from intraerythrocytic parasites treated with INA. For other
fluorescence dyes, P. falciparum cultures were incubated with probes for
1 h at the following concentrations: Nile Red, 1 mg/ml; rhodamine 123,
10 ng/ml; and LysoTrackerH Red DND-99, 75 nM. Cells were not washed
prior to fluorescence microscopy to minimize damage due to osmotic
changes. Scale bar, 3 mm. An arrow indicates a lipid body in (B).
doi:10.1371/journal.pone.0032246.g003
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during various treatments for microscopy.
In order to maintain the various functions and stability of
plasma membranes, different organisms synthesize several specific
components for their biological membranes. For example, sterols,
a vast family of isoprenoids, take pivotal role with mammalian and
fungal cells generally synthesizing one major sterol, cholesterol and
ergosterol, respectively [23], [27]. Plants, on the other hand, are
known to produce a characteristically complex sterol mixture. As
many as 61 sterols and isoprenoids have been identified in a single
maize seedling [28]. Prokaryotes produce hopanoids, pentacyclic
isoprenoids, by direct cyclization of squalene (Fig. 1) [29]. The
functions of the hopanoids were shown to be equivalent to sterols:
functioning as membrane reinforcers affecting membrane perme-
ability and fluidity. In protozoa, there has been one report that
Tetrahymena synthesizes tetrahymanol, a quasi-hopanoid, together
with small amounts of diplopterol [30], [31]. Both components
were incorporated into its membranes.
Enzymes that are involved in gibberellin biosynthesis are also of
importance in the formation of such sterols and other membrane
constituents. Change in the level of these substances after treatment
with inhibitors has been often observed as side activities for these
inhibitors [15]. For example, AMO-1618 inhibits syntheses of
phytosterols and cholesterol, by blocking cycloartenol synthase (CAS)
in plants and lanosterol synthase (LS) in animals, respectively [32].
We analyzed P. falciparum treated with INA and AMO-1618 by
GC-MS in order to identify sterols or isoprenoids in malaria
parasites, but we couldnot detect any isoprenoids, besidescholesterol
(Fig. 6). We might be able to hypothesize that responsible
components could be too low or structurally unknown to detect by
GC-MS in parasite cells. Data about syntheses of isoprenoids in
protozoa, especially in Apicomplexa, remains nil. Intraerythrocytic
parasites are known to intake large amounts of erythrocyte contents
with surrounding membranes that are cholesterol rich, however,
cholesterol is greatly depleted in parasite membranes (Fig. 6 A) [33].
How parasites transport and dispose of excess cholesterol within the
cells remain a puzzle. Additionally, does lack of isoprenoids make
membranesleakyeveninintracellularparasites?Apreviousstudyhas
demonstrated by differential scanning calorimetry and electron spin
resonance the association of gibberellin molecules with phospholipid
membranes thereby altering the fluidity or viscosity of the lipid
bilayer [34]. Clearly, further studies on gibberellin biosynthetic
inhibitors could shed light if these compounds could perturb lipid
bilayers or alter properties of the membrane phospholipid.
Figure 4. Transmission electron microscopy of parasitized erythrocytes treated with inhibitors. (A) Sections through an erythrocyte
containing a trophozoite-stage parasite exposed to 0.1% DMSO for 6 h, 50 mM INA for 6 h or 250 mM AMO-1618 for 8 h, respectively. (B)
Asynchronized parasites were treated with 0.1% DMSO (a–d) or 50 mM INA for 6 h (e–h). Sections from representative stages during intraerythrocytic
development: ring- (a and e), early trophozoite- (b and f), mature trophozoite- (c and g) and schizont-stage parasites (d and h) are shown. Nuclei (n),
food vacuoles (fv), merozoites (m), nuclei of merozoites (mn) and abnormal gaps between the nuclei and the nuclear envelopes (arrowheads) are
indicated. Scale bar is indicated at the bottom of the images.
doi:10.1371/journal.pone.0032246.g004
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e32246The gibberellin biosynthetic inhibitors are known to be specific
for isoprenoid biosynthesis in plants. We searched amino acid
sequences and conserved domain sequences essential for these
enzymes using PlasmoDB, but no sequences with significant
homologies were found. This may imply the uniqueness of
isoprenoid metabolic pathways in Apicomplexa, and consequently,
provide potent targets to develop novel therapeutic agents.
Supporting Information
Figure S1 Concentration-response curve of INA. Each
point represents the mean 6 standard deviations (SD) from three
independent experiments, with each treatment duplicated twice.
(TIF)
Figure S2 Chiral separation of enantiomeric INA.
Racemic form of INA was separated on Chiralcel OD column.
Mobile phase: n-hexane-2-propanol (8:2, v/v), flow rate:10 ml/
min, detection: 275 nm. HPLC chromatograms of each enantio-
mer are also shown.
(TIF)
Figure S3 Effect of gibberellin biosynthetic inhibitors
on the intraerythrocytic development of P. falciparum.
Asynchronized parasites were treated with 200 mM FC-907 for
24 h, 500 mM uniconazole P for 8 h, 200 mM paclobutrazol for
8h ,5 0mM INA or 1 ml/ml DMSO for 6 h. Giemsa-stained thin
blood smears were prepared from each sample after the indicated
treatment and examined under a microscope. Each panel shows
the typical morphology of trophozoite-stage parasites in each
treatment. Scale bar, 3 mm.
(TIF)
Figure S4 Effects of gibberellin biosynthetic inhibitors
on the viability of erythrocytes to support growth of P.
falciparum. Erythrocytes that had been incubated in RPMI
Figure 5. Effects of osmotic pressure to intraerythrocytic
parasites treated with INA. (A) Effects of hyperosmotic stress in
INA-treated parasites. P. falciparum cultures treated with 50 mM INA
were observed in various dilution ratios of PBS for 8 h. Parasitemia was
determined by Giemsa-stained thin blood smears. Student’s t-test:
*P.0.005. Values are means 6 SD of n=6 in two independent
experiments. Data were normalized relative to control cultures (16PBS)
in DMSO- and INA-treated samples, respectively. Representative
parasite morphologies are shown for each treatment. Scale bar, 3 mm.
(B) Effects of hyposmotic stress, experimentally induced by the addition
of water to the culture medium of P. falciparum, after 8 h of 50 mM INA
treatment. N=6 smears each in two independent experiments.
doi:10.1371/journal.pone.0032246.g005
Figure 6. GC-MS analysis of isoprenoids in P. falciparum in vitro
cultures. (A) Total ion chromatograms of extracts from unparasitized
erythrocytes (Unparasitized), parasites treated with 0.1% DMSO, 250 mM
AMO-1618, and 50 mM INA for 6 h. Triangles and circles indicate the
peaks of geranylgeraniol mixed as an internal control (retention
time=6.57 min) and cholesterol (11.23 min), respectively. These com-
pounds were identified by direct comparison with authentic samples. (B)
Quantification of cholesterol in each treated sample. Cholesterol amount
wascalculated fromthepeak areas andnormalized relative totheratio of
theinternalcontrolgeranylgeraniol.ValuesaremeansandSDoftriplicate
measurements of a representative experiment.
doi:10.1371/journal.pone.0032246.g006
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PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e322461640 containing 10% human serum and supplemented with
1 ml/ml DMSO, 50 mM INA or 250 mM AMO-1618 for 24 h
were washed with RPMI 1640 twice and mixed with P. falciparum
infected erythrocytes at 0.3% starting parasitemia. Thin blood
films from each culture were prepared after 48 h, stained with
Giemsa and parasitemias were counted under a microscope.
Values are mean 6 SD of n=3 in each representative
experiment.
(TIF)
Figure S5 Influence of INA concentration on growth
inhibition in P. falciparum. (A) Synchronized parasites at
early trophozoite stage were treated with 0 (1 ml/ml DMSO), 10
or 50 mM INA for 0–8 h. Parasitemia was determined by thin
blood films after staining with Giemsa. Error bars represent the
standard deviation (SD) of three independent experiments made in
duplicate. Data are normalized relative to those for the control
treated for 0 h. (B) The parasites treated with 0, 10 or 50 mM INA
after 4 h, stained with Giemsa, and visualized under light
microscope. Scale bar=3 mm. Each panel shows the typical
morphology of trophozoite-stage parasites in each treatment.
(TIF)
Figure S6 Effects of cation species to the parasitemia of
the intraerythrocytic parasites treated with INA. Syn-
chronized parasites at early trophozoite stage were mixed with
10% of 16and 46normal PBS or the solution that Na
+ and K
+
concentrations in PBS are exchanged (reversed-PBS; 16reversed-
PBS contains 137 mM KCl, 8.1 mM K2HPO4, 2.68 mM NaCl,
1.47 mM NaH2PO4), and treated with 50 mM INA or 1 ml/ml
DMSO for 8 h. Parasitemia was determined by counting thin
blood film from each culture blindly after staining with Giemsa;
the counter was blinded to sample identities. Error bars represent
the standard deviation of three independent experiments made in
duplicate. Data are normalized relative to those for the control
treated with 16PBS and 1 ml/ml DMSO.
(TIF)
Figure S7 Influence of Ca
2+ on the effects of INA in P.
falciparum. Parasites were synchronized by 5% sorbitol
treatment and treated with 1 ml/ml DMSO or 50 mM INA with
or without adding 100 mM CaCl2 after 18 h of incubation. The
parasites were examined at 6 h of the treatment by thin blood
smears and staining with Giemsa. Scale bar indicates 3 mm. Each
panel shows a typical morphology of trophozoite-stage parasites in
each treatment.
(TIF)
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